Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent a promising tool for new clinical concepts in supporting cellular therapy. Bone marrow (BM) was the first source reported to contain MSCs. However, for clinical use, BM may be detrimental due to the highly invasive donation procedure and the decline in MSC number and differentiation potential with increasing age. More recently, umbilical cord blood (UCB), attainable by a less invasive method, was introduced as an alternative source for MSCs. Another promising source is adipose tissue (AT). We compared MSCs derived from these sources regarding morphology, the success rate of isolating MSCs, colony frequency, expansion potential, multiple differentiation capacity, and immune phenotype. No significant differences concerning the morphology and immune phenotype of the MSCs derived from these sources were obvious. Differences could be observed concerning the success rate of isolating MSCs, which was 100% for BM and AT, but only 63% for UCB. The colony frequency was lowest in UCB, whereas it was highest in AT. However, UCB-MSCs could be cultured longest and showed the highest proliferation capacity, whereas BM-MSCs possessed the shortest culture period and the lowest proliferation capacity. Most strikingly, UCB-MSCs showed no adipogenic differentiation capacity, in contrast to BM- and AT-MSCs. Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As plating density can affect proliferation kinetics of MSCs [16, 23], cells from all tissue sources were grown for at least two passages under two seeding densities: 300 and 3000 cells/cm2.”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., et al. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.003 · Cited by 1,259
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Kögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029
Research works printed but not linked: 1
- 10.1210/endo.134.1.8275945 · doi:10.1210/endo.134.1.8275945 · Paper page
Cited by
Items 901–1,000 of 1,013
Mohammadi, R., Azizi, S., Delirezh, N., Hobbenaghi, R., & Amini, K. (2010) · Muscle & Nerve · doi:10.1002/mus.21895 · Cited by 53
Jin, H. J., Nam, H. Y., Bae, Y. K., Kim, S. Y., Im, I. R., Oh, W., Yang, Y. S., Choi, S. J., & Kim, S. W. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0292-z · Cited by 56
“After the differentiation under specific induction conditions, the multi-lineage potentials of UCB-MSCs and BM-MSCs were evaluated as previously reported [ 6 , 24].”
BackgroundResultA putative mesenchymal stem cells population isolated from adult human testes
Gonzalez, R., Griparic, L., Vargas, V., Burgee, K., Santacruz, P., Anderson, R. E., Schiewe, M. C., Silva, F., & Patel, A. N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.103 · Cited by 58
Sharma, M., Bellio, M. A., Benny, M., Kulandavelu, S., Chen, P., Janjindamai, C., Han, C., Chang, L., Sterling, S., Williams, K., et al. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac041 · Cited by 52
“42-45 In our study, while rats that received WJ-MSC EVs had less RVH and a trend for less mortality compared to those who received BM-MSC EVs, there was no significant difference in the lung alveolar and vascular structure.”
Dudakovic, A., Camilleri, E. T., Lewallen, E. A., McGee‐Lawrence, M. E., Riester, S. M., Kakar, S., Montecino, M. A., Stein, G. S., Ryoo, H., Dietz, A. B., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24680 · Cited by 54
“Histone deacetylase inhibitors (HDIs), including suberoylanilide hydroxamic acid (SAHA, vorinostat, ZolinzaTM), are used clinically for the treatment of some cancer types, as well as non-life-threatening conditions like mood disorders and epilepsy (Peterson and Laniel, 2004; Kim and Bae, 2011).”
BackgroundTissue regeneration potential in human umbilical cord blood
Arien‐Zakay, H., Lazarovici, P., & Nagler, A. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.04.001 · Cited by 58
“It is accepted that MSCs have the capacity to regeneratemesenchymal tissues and blood cells and can give rise tomultiple types of mesodermal tissue, including bone, cartilage, tendon, muscle, fat and marrow stroma [5–7].”
BackgroundCharoenpanich, A., Wall, M. E., Tucker, C. J., Andrews, D. M. K., Lalush, D. S., & Loboa, E. G. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0107 · Cited by 57
Keung, E. Z.-Y., Nelson, P. J., & Conrad, C. H. (2013) · Stem Cells · doi:10.1002/stem.1269 · Cited by 57
Cavallo, C., Cuomo, C., Fantini, S., Ricci, F., Tazzari, P. L., Lucarelli, E., Donati, D. M., Facchini, A., Lisignoli, G., Fornasari, P. M., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23058 · Cited by 52
Umbilical cord blood mesenchymal stem cells
Musina, R. A., Bekchanova, E. S., Belyavsky, A. V., Grinenko, T., & Sukhikh, G. T. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0032-z · Cited by 55
Somal, A., Bhat, I. A., Indu, B., Pandey, S., Panda, B. S. K., Thakur, N., Sarkar, M., Chandra, V., Saikumar, G., & Sharma, G. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156821 · Cited by 52
Pill, K., Melke, J., Mühleder, S., Pultar, M., Rohringer, S., Priglinger, E., Redl, H. R., Hofmann, S., & Holnthoner, W. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00156 · Cited by 57
“Retroviral Infection HUVEC were retrovirally infected with yellow fluorescent protein (YFP), green fluorescent protein (GFP) or red fluorescent protein (mCherry) to document network-formation over time as previously described (Knezevic et al., 2017).”
MethodCarluccio, M., Ziberi, S., Zuccarini, M., Giuliani, P., Caciagli, F., Iorio, P. D., & Ciccarelli, R. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09703-4 · Cited by 57
Lv, X., Guan, C.-Y., Li, Y., Su, X., Zhang, L., Wang, X., Xia, H., & Ma, X. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00871-4 · Cited by 52
Concepts for the clinical use of stem cells in equine medicine.
Koch, T. G., Berg, L. C., & Betts, D. H. (2008) · PubMed · Cited by 66
Mohanram, Y., Zhang, J., Tsiridis, E. E., & Yang, X. (2020) · Cytotechnology · doi:10.1007/s10616-020-00414-7 · Cited by 51
Riedl, J., Popp, C. M., Eide, C. R., Ebens, C. L., & Tolar, J. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.06.004 · Cited by 56
Liang, L., Ma, T., Chen, W., Hu, J., Bai, X., Li, J., & Liang, T. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00506.x · Cited by 52
Wei, X., Hu, Y., Xie, W., Lin, R., & Chen, G. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32146 · Cited by 56
Development of cellular therapy for the treatment of stress urinary incontinence
Wang, H., Chuang, Y., & Chancellor, M. B. (2011) · International Urogynecology Journal · doi:10.1007/s00192-011-1432-1 · Cited by 51
“However, for clinical use, bone marrow may be detrimental due to the highly invasive and painful procedures required for procurement, decline in differentiation potential and MSC number with increased age, and low yield of MSCs upon processing [37, 56].”
Bakhshandeh, B., Soleimani, M., Hafizi, M., & Ghaemi, N. (2012) · Cytotechnology · doi:10.1007/s10616-012-9430-9 · Cited by 51
“Although bone marrow is considered as an accessible and enriched source of hMSC, the isolation procedure is invasive for donors and patients (Kern et al. 2006).”
BackgroundWang, Z., Teoh, S. H., Johana, N. B., Chong, M. S. K., Teo, E. Y., Hong, M., Chan, J. K. Y., & Thian, E. S. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00522h · Cited by 51
Mesenchymal stromal cells: properties and role in management of cutaneous diseases
Kim, K. H., Blasco‐Morente, G., Cuende, N., & Arias‐Santiago, S. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13934 · Cited by 56
Arthroscopic Harvest of Adipose-Derived Mesenchymal Stem Cells From the Infrapatellar Fat Pad
Dragoo, J. L., & Chang, W. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517719454 · Cited by 51
Park, J., Lee, J. H., Yoon, B. S., Jun, E. K., Lee, G., Kim, I. Y., & You, S. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1058-z · Cited by 54
de Castro, L. L., Kitoko, J. Z., Xisto, D. G., Olsen, P. C., Guedes, H. L. D. M., Morales, M. M., Lopes‐Pacheco, M., Cruz, F. F., & Rocco, P. R. M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0120 · Cited by 51
Jeske, R., Yuan, X., Fu, Q., Bunnell, B. A., Logan, T. M., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621744 · Cited by 56
Chang, T.-H., Wu, C., Chiou, S., Chang, C.-H., & Liao, H. (2022) · Biomedicines · doi:10.3390/biomedicines10071725 · Cited by 52
“Among all adult stem cells, SC-MSCs and BMSCs have identical properties [84] and are relatively accessible and abundant.”
BackgroundBehr, B., Ko, S. H., Wong, V., Gurtner, G. C., & Longaker, M. T. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181ea42bb · Cited by 70
Lv, Z., Cai, X., Bian, Y., Wei, Z., Zhu, W., Zhao, X., & Weng, X. (2023) · Bioengineering · doi:10.3390/bioengineering10020195 · Cited by 56
“In general, the proliferative capacity of MSCs obtained from fetal tissue is more out‐ standing than that of MSCs obtained from adult tissue; additionally, umbilical cord, am‐ niotic membrane, and fat sources are more accessible and possess a higher proliferative capacity, while the proliferation ability of bone marro…”
Role of adipose-derived stem cells in chronic cutaneous wound healing.
Caruana, G., Bertozzi, N., Boschi, E., Grieco, M. P., Grignaffini, E., & Raposio, E. (2015) · PubMed · Cited by 53
Stem cells for tissue engineering of articular cartilage
Gao, J., Yao, J. Q., & Caplan, A. I. (2007) · Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine · doi:10.1243/09544119jeim257 · Cited by 59
Li, Q., Tang, J., Wang, R., Bei, C., Xin, L., Zeng, Y., & Tang, X. (2010) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.3109/10731191003776769 · Cited by 50
“The differentiation potentials and functional implications vary widely among MSCs derived from different tissues [13].”
BackgroundOsteogenesis of human stem cells in silk biomaterial for regenerative therapy
Kundu, B., & Kundu, S. C. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.004 · Cited by 54
Xu, Y., Meng, H., Li, C., Hao, M., Wang, Y., Yu, Z., Li, Q., Jun-ling, H., Zhai, Q.-L., & Qiu, L. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0321 · Cited by 50
“Furthermore, compared with MSCs derived from BM or UCB, the expression of HLA-ABC is apparently lower [ 23 ].”
Kim, S., Park, K. C., Lee, J. U., Kim, K.-J., & Kim, D.-G. (2011) · Journal of the Korean Surgical Society · doi:10.4174/jkss.2011.81.3.176 · Cited by 53
Acellular Dermal Matrix Seeded with Adipose-Derived Stem Cells as a Subcutaneous Implant
Orbay, H., Takami, Y., Hyakusoku, H., & Mizuno, H. (2011) · Aesthetic Plastic Surgery · doi:10.1007/s00266-011-9683-2 · Cited by 50
“from subcutaneous adipose tissue without any type of highly invasive, painful procedures [9, 35].”
BackgroundThe Use of Stem Cells in Plastic and Reconstructive Surgery
Koźlik, M. J., & Wójcicki, P. (2014) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/37360 · Cited by 56
Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain
Seymour, T., Twigger, A., & Kakulas, F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126024 · Cited by 50
“By this definition, MSCs can be identified in a range of other adult human tissues and fluids, such as peripheral blood, umbilical cord blood, adipose tissue, saliva and the dental pulp [25–29].”
BackgroundMesenchymal stem cell-based therapy in kidney transplantation
Cheng, C., & Hou, J. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0283-6 · Cited by 53
“Umbilical cord blood mesenchymal stem cells are the youngest MSCs, with the highest potential and lowest immunogenicity [31, 32].”
BackgroundAshour, R. H., Saad, M. A., Sobh, M.-A., Al-Husseiny, F., Abouelkheir, M. M., Awad, A., Elghannam, D. M., Abdel-Ghaffar, H., & Sobh, M. A. K. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0386-0 · Cited by 50
Paz, A. G., Maghaireh, H., & Mangano, F. G. (2018) · Stem Cells International · doi:10.1155/2018/4313610 · Cited by 55
“ASCs are expected to be an alternative source of MSCS in bone regeneration in the dental field, as they present a robust osteogenesis [58].”
BackgroundGinsenoside Rg1 as an Effective Regulator of Mesenchymal Stem Cells
He, F., Yu, C., Liu, T., & Jia, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01565 · Cited by 51
“For instance, RUNX2 is a transcription factor belonging to the RUNX family and plays a key role in osteoblast differentiation (Komori, 2018).”
BackgroundAdipose Tissue: A Source of Stem Cells with Potential for Regenerative Therapies for Wound Healing
Trevor, L. V., Riches‐Suman, K., Mahajan, A., & Thornton, M. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072161 · Cited by 58
Öztürk, S., Elçin, A. E., Koca, A., & Elçin, Y. M. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10029-2 · Cited by 52
Xue, S., Zhang, H., Zhang, P., Luo, J. D., Chen, Z., Jang, X.-D., & Xu, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.035 · Cited by 53
Lin, L., Shen, Q., Wei, X., Hou, Y., Xue, T., Fu, X., Duan, X., & Yu, C. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9250-x · Cited by 52
“ADSCs are easily and abundantly available and carry a relatively lower donor site morbidity, and attaining large numbers of stem cells at harvest could reduce or even eliminate the need for costly and lengthy tissue culture expansion that would subject the patient to a staged second procedure [3].”
Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells
Bakhshandeh, B., Hafizi, M., Ghaemi, N., & Soleimani, M. (2012) · Biotechnology Letters · doi:10.1007/s10529-012-0934-3 · Cited by 51
Participation of TNF‐α in Inhibitory Effects of Adipocytes on Osteoblast Differentiation
Abuna, R. P. F., Oliveira, F. S., Santos, T. D. S., GUERRA, T. R., Rosa, A. L., & Beloti, M. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25073 · Cited by 59
Yu, Y., Song, Y., Chen, Y., Zhang, F., & Qi, F. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9181 · Cited by 49
“Mean values of cell counts were calculated, and the mean population doubling of each passage was obtained according to the following formula: PD=(logNt-logN0)/log 2, where Nt is the harvested cell number and N0 is the initial cell number for each passage (13).”
Ahmadzadeh, N., Robering, J. W., Kengelbach‐Weigand, A., Al‐Abboodi, M., Beier, J. P., Horch, R. E., & Boos, A. M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111816 · Cited by 50
Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications
Ouzin, M., & Kogler, G. (2023) · Cells · doi:10.3390/cells12162039 · Cited by 42
“MSCs isolated from cord blood have been shown to have a unique chondrogenic differentiation potential in vivo and reveal higher replicative rates compared to BM-MSCs [51,57,109].”
BackgroundInfluentialTherapeutic effect of mesenchymal stem cells and their derived exosomes in diseases
Wang, Y., Wang, H., Tan, J. Y., Cao, Z., Wang, Q., Wang, H., Yue, S., Li, W., & Wang, D. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00277-4 · Cited by 55
“Therefore, this also increases the motivation for donors to donate AD-MSCs. Compared with BM-MSCs, AD-MSCs have more stable morphological and genetic characteristics, higher proliferative activity and lower senescence rate under the same in vitro culture conditions [33, 34].”
Fan, W., Sun, D., Liu, J., Dong, L., Wang, Y., Narsinh, K. H., Li, Y., Qin, X., Liang, J., Tian, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045621 · Cited by 52
“Cells were cultured and identified for immunophenotype and multipotency using previous procedures with minor modifications [15,16] (see Methods S1).”
MethodAmable, P. R., Teixeira, M. V. T., Carias, R. B. V., Granjeiro, J. M., & Borojević, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073792 · Cited by 53
“Cells obtained from different sources have different properties that are increasingly studied in vitro in the last years [14–16] but much information is still missing.”
BackgroundSchuh, E. M., Friedman, M. S., Carrade, D. D., Li, J., Heeke, D., Oyserman, S. M., Galuppo, L. D., Lara, D. J., Walker, N. J., Ferraro, G. L., et al. (2009) · American Journal of Veterinary Research · doi:10.2460/ajvr.70.12.1526 · Cited by 55
Ribeiro‐Samy, S., Silva, N. A., Correlo, V. M., Fraga, J. S., Pinto, L., Teixeira‐Castro, A., Leite‐Almeida, H., Almeida, A., Gimble, J. M., Sousa, N., et al. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300178 · Cited by 54
Human adipose-derived stem cells: Potential clinical applications in surgery
Utsunomiya, T., Shimada, M., Imura, S., Morine, Y., Ikemoto, T., Mori, H., Hanaoka, J., Iwahashi, S., Saito, Y., & Iwaguro, H. (2010) · Surgery Today · doi:10.1007/s00595-010-4415-9 · Cited by 54
“Although umbilical cord blood also contains mesenchymal stem cells, the use of these cells has been restricted by practical diffi culties in obtaining and isolating the mesenchymal stem cells at the time of birth, thereby ensuring adequate long-term storage for autologous use.(10) Adipose tissue is highly complex and…”
BackgroundSobreiro‐Almeida, R., Tamaño-Machiavello, M. N., Carvalho, E. O., Cordón, L., Doria, S., Senent, L., Correia, D. M., Ribeiro, C., Lanceros-Méndez, S., Serra, R. S. I., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112391 · Cited by 49
Arnhold, S., Elashry, M. I., Klymiuk, M. C., & Geburek, F. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1429-0 · Cited by 52
Jia, Z., Wang, S., & Liu, Q. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14891 · Cited by 57
Gómez-Leduc, T., Hervieu, M., Legendre, F., Bouyoucef, M., Gruchy, N., Poulain, L., de Vienne, C. M., Herlicoviez, M., Demoor, M., & Galéra, P. (2016) · Scientific Reports · doi:10.1038/srep32786 · Cited by 48
Extracellular Hemoglobin: Modulation of Cellular Functions and Pathophysiological Effects
Drvenica, I. T., Stančić, A. Z., Maslovarić, I. S., Trivanović, D. I., & Ilić, V. L. (2022) · Biomolecules · doi:10.3390/biom12111708 · Cited by 52
Umbilical Cord Blood-Derived Stem Cells Spontaneously Express Cardiomyogenic Traits
Prat‐Vidal, C., Roura, S., Farré, J., Gálvez‐Montón, C., Llach, A., Molina, C. E., Hove‐Madsen, L., Garcia, J., Cinca, J., & Bayés‐Genís, A. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.06.016 · Cited by 48
Mesenchymal stem cell–based therapy for nonhealing wounds: today and tomorrow
Li, M., Zhao, Y., Hao, H., Han, W., & Fu, X. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12304 · Cited by 49
Differential marker expression by cultures rich in mesenchymal stem cells
Wetzig, A. R., Alaiya, A. A., Al-Alwan, M. M., Pradez, C. B., Manogaran, P. S., Al‐Mazrou, A., Shinwari, Z., Sleiman, G. M., Ghebeh, H., Alhumaidan, H., et al. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-54 · Cited by 48
“Hence, no selection or sorting techniques were applied to our tissue cultures, save for those prescribed by Dominici et al 2006 [14]; plastic adherence and proliferation in standard tissue culture conditions.”
MethodNakahara, T. (2011) · Odontology · doi:10.1007/s10266-011-0037-y · Cited by 65
Śmieszek, A., Donesz‐Sikorska, A., Grzesiak, J., Krzak, J., & Marycz, K. (2014) · Journal of Biomaterials Applications · doi:10.1177/0885328214545095 · Cited by 48
Yang, S., Huang, S., Feng, C., & Fu, X. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0175-9 · Cited by 51
Nishino, Y., Ebisawa, K., Yamada, Y. M. A., Okabe, K., Kamei, Y., & Ueda, M. (2011) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e318207b507 · Cited by 55
“In addition, the number, proliferation, and differentiation potential of MSCs decline with increasing age.(8) Dental pulp appears to be an alternate and more readily available source of stem cells in the craniofacial area.”
BackgroundNaderi, N., Wilde, C., Haque, T., Francis, W., Seifalian, A. M., Thornton, C. A., Xia, Z., & Whitaker, I. S. (2014) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2014.08.013 · Cited by 48
Gao, Z., Zhang, Q., Han, Y., Cheng, X., Lu, Y., Fan, L., & Wu, Z. (2011) · Cytotherapy · doi:10.3109/14653249.2011.616194 · Cited by 49
Adipose-derived stem cell-based treatment for acute liver failure
Chen, G., Jin, Y., Shi, X., Qiu, Y., Zhang, Y., Cheng, M., Wang, X., Chen, C., Wu, Y., Jiang, F., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0040-2 · Cited by 51
“Although BMSCs are considered a benchmark for clinic purposes, BMSC isolation involves an invasive and painful procedure characterized by low yield [29-31].”
BackgroundInfluentialMonsarrat, P., Vergnes, J., Planat‐Benard, V., Ravaud, P., Kémoun, P., Sensebé, L., & Casteilla, L. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0329 · Cited by 49
Aliborzi, G., Vahdati, A., Mehrabani, D., Hosseini, S. E., & Tamadon, A. (2016) · International Journal of Stem Cells · doi:10.15283/ijsc.2016.9.1.115 · Cited by 52
Perlee, D., de Vos, A. F., Scicluna, B. P., Mancheño‐Corvo, P., de la Rosa, O., Dalemans, W., Nürnberg, P., Lombardo, E., & van der Poll, T. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0260 · Cited by 51
Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos
Alonso-Alonso, M. L., García-Posadas, L., & Diebold, Y. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10155-5 · Cited by 50
Zhang, W., Ling, Q., Wang, B., Wang, K., Pang, J., Lü, J., Bi, Y., & Zhu, D. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02974-1 · Cited by 50
“Moreover, UC-MSCs exhibit stronger proliferative capacities than BM-MSCs in vitro [48, 49], which leads to higher cell yields and a sufficient supply for clinical demands.”
BackgroundNi, W., Fang, Y., Xie, L., Liu, X., Wei, S., Zeng, R., Liu, J., & Liu, X. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415599039 · Cited by 51
“ADMSCs and BMMSCs share similar characteristics regarding morphology and immune phenotype (Kern et al. 2006).”
BackgroundGiesel, F. L., Stroick, M., Griebe, M., Tr�ster, H., der Lieth, C. W. V., Requardt, M., Rius, M., Essig, M., Kauczor, H., Hennerici, M. G., et al. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000246147.44835.4c · Cited by 48
“Cells were processed and characterized as described previously.(25) According to Daldrup-Link et al,(9) a modified protocol with and without Lipofectin (Invitrogen, Karlsruhe, Germany) as an uptake mediator for the gadolinium chelate was used.”
MethodHuman adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents
Liang, W., Xia, H., Li, J., & Zhao, R. C. (2011) · Cytotechnology · doi:10.1007/s10616-011-9374-5 · Cited by 47
“…clinical use, the isolation and the harvest of bone marrow MSCs is a highly invasive procedure and the number, differentiation potential, and maximal life span of bone marrow MSCs decline with increasing age and could be clinically inefficient when derived from elderly patients (Kern et al. 2006).”
BackgroundInfluentialA Comparative Study of Proliferation and Hepatic Differentiation of Human Adipose-Derived Stem Cells
Coradeghini, R., Guida, C., Scanarotti, C., Sanguineti, R., Bassi, A. M., Parodi, A., Santi, P., & Raposio, E. (2009) · Cells Tissues Organs · doi:10.1159/000273266 · Cited by 52
“This kind of cells possess many characteristics of mesenchymal stem cells (MSC): low levels of cell senescence even after multiple passages; analogous surface antigen marker profile of bone marrow-derived MSC, consisting in the expression of CD146, CD106, CD105, CD90, CD73, CD54, CD49(d), CD49(e), CD44 [Gronthos et al…”
BackgroundMethodInfluentialCell transplantation and secretome based approaches in spinal cord injury regenerative medicine
Silva, R. C. A., Pinto, L., & Salgado, A. J. (2021) · Medicinal Research Reviews · doi:10.1002/med.21865 · Cited by 49
“2 | MSC secretory profile from a mechanistic point of view Differences among MSC populations go beyond donor and experimental disparity,(338) and include tissue‐source variations in respect to cell‐surface markers expression, yield and expandability, differentiation patterns, and epitope profile.(69,340,341) Thus, it…”
BackgroundMesenchymal Stem Cells: From Identification and Characterization to Clinical Applications
Álvarez‐Viejo, M., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_6-1 · Cited by 48
Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood–Derived Cells
Damien, P., & Allan, D. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.05.022 · Cited by 53
“Moreover, national blood operators in some jurisdictions have embraced manufacturing of MSCs for human use [7,8] and an increasing number of academic institutions and private companies are investing in cell manufacturing facilities to accommodate MSC-based clinical applications.”
BackgroundShen, H., Wang, Y., Zhang, Z., Yang, J., Hu, S., & Shen, Z. (2015) · Stem Cells International · doi:10.1155/2015/524756 · Cited by 52
Corradetti, B., Correani, A., Romaldini, A., Marini, M. G., Bizzaro, D., Perrini, C., Cremonesi, F., & Lange-Consiglio, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111324 · Cited by 47
Current Status of Human Adipose–Derived Stem Cells: Differentiation into Hepatocyte-Like Cells
Battah, F. A., Kock, J. D., Vanhaecke, T., & Rogiers, V. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.146 · Cited by 54
“Based on their biological properties, including growth kinetics, cell surface phenotype, gene expression, and differentiation potential, these cells have properties that are similar to those of bone marrow–derived MSCs (BMMSCs)[10,11,12].”
BackgroundPostnatal stem/progenitor cells derived from the dental pulp of adult chimpanzee
Cheng, P., Snyder, B. R., Fillos, D., Ibegbu, C., Huang, A. H., & Chan, A. W. S. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-20 · Cited by 58
“According to the current classification and criteria of BMSCs [45,52,53], DPSCs are considered to have a lower differentiation potential, with variations in cell surface marker profiles, compared to that of BMSCs [3].”
ResultYang, L., Cheng, F., Liu, T., Lu, J. R., Song, K., Jiang, L., Wu, S., & Guo, W. (2012) · Biomedical Materials · doi:10.1088/1748-6041/7/3/035003 · Cited by 51
Conese, M., Carbone, A., Castellani, S., & Gioia, S. D. (2013) · Cells Tissues Organs · doi:10.1159/000348831 · Cited by 49
“, 2006], MSCs isolated from different sources generally express comparable cell surface markers and differentiate along recognized lineage pathways, but also differ in gene expression and lineage differentiation [De Ugarte et al., 2003; Panepucci et al., 2004; Chang et al., 2006; Kern et al., 2006], as well as in immu…”
BackgroundKim, S.-J., Choi, Y., Ko, E.-S., Lim, S., Lee, C., & Kim, D. (2012) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2012.02.007 · Cited by 47
Human adipose derived stroma/stem cells grow in serum-free medium as floating spheres
Dromard, C., Bourin, P., André, M., Barros, S. D., Casteilla, L., & Planat‐Benard, V. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.001 · Cited by 53
Su, Z., Li, P., Wu, B., Ma, H., Wang, Y., Liu, G., Zeng, H., Li, Z., & Wei, X. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.09.022 · Cited by 47
A Simple Modification of the Separation Method Reduces Heterogeneity of Adipose-Derived Stem Cells
Griesche, N., Luttmann, W., Luttmann, A., Stammermann, T., Geiger, H., & Baer, P. C. (2010) · Cells Tissues Organs · doi:10.1159/000289586 · Cited by 52
“MSCs can be isolated from different sources like bone marrow, umbilical cord blood and adipose tissue with only slight differences [Dicker et al., 2005; Wagner et al., 2005; Kern et al., 2006; Banas et al., 2007].”
BackgroundFarea, M., Husein, A., Halim, A. S., Nurul, A. A., Mokhtar, K. I., Lim, C. K., Berahim, Z., & Mokhtar, K. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.08.015 · Cited by 52
“Moreover, the number, proliferation, and differentiation potential of BMMSCs decline with increasing age.(30) Compared to dental pulp stem cells (DPSCs) and BMMSCs, SHED had the highest proliferative capacity with abundance of extracellular matrix and growth factors.”
BackgroundRutigliano, L., Corradetti, B., Valentini, L., Bizzaro, D., Meucci, A., Cremonesi, F., & Lange-Consiglio, A. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt344 · Cited by 50
Samorezov, J. E., Headley, E. B., Everett, C. R., & Alsberg, E. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35668 · Cited by 50
Potential Therapeutic Applications of Adipose-Derived Mesenchymal Stem Cells
Lo Furno, D., Mannino, G., Cardile, V., Parenti, R., & Giuffrida, R. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0135 · Cited by 46
“Although initial evidence indicated equal [60,61] or higher chondrogenic potential for BMSCs than ASCs [62], some authors reported opposite results [63].”
Moraghebi, R., Kirkeby, A., Cháves, P., Rönn, R. E., Sitnicka, E., Parmar, M., Larsson, M., Herbst, A., & Woods, N. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0582-6 · Cited by 48
Metadata
- Authors
- Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K.
- Affiliations
- German Red Cross (DE)
- Department of Orthopaedic Surgery of the University Hospital Mannheim, University of Heidelberg, Faculty of Clinical Medicine, Mannheim, Germany
- Corresponding author
- Bieback, Karen
- Venue
- STEM CELLS
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05
- Volume
- 24
- Issue
- 5
- Pages
- 1294-1301
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2036348189
- Cited by
- 3,370
- References
- 37
- Citations by year
- 2026: 57 · 2025: 97 · 2024: 142 · 2023: 136 · 2022: 176 · 2021: 201 · 2020: 225 · 2019: 197 · 2018: 190 · 2017: 193 · 2016: 208 · 2015: 218 · 2014: 225 · 2013: 242 · 2012: 213
- FWCI
- 49.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, bone marrow, umbilical cord blood, adipose tissue, stem cell isolation, adipogenesis, multilineage differentiation, immunophenotype, stem cell expansion, cell therapy
- MeSH terms
- Adipose Tissue, Aged, Aged, 80 and over, Antigens, Surface, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Fetal Blood, Humans, Osteogenesis, Immunophenotyping, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.